BioRestorative Therapies, Inc.
- BRTX
- NASDAQ
- Biotechnology
- Adult Stem Cell Therapy
- Disc/Spine & Metabolic
$1.54
Today +5.48%Quote Oct 16, 2026, 08:00 PM UTC
−42.00%over the last month
Max drawdown −46.1%From 1-month high −43.2%3 months −76.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$39.2M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$1.43
7.1% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BRTXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q1 2026 revenue $23,170
- Product$11,87051.2%
- Royalty$11,30048.8%
Industry
Biotechnology
Employees
14
Founded
1997